story of the week
Renin–Angiotensin System Modulation With Synthetic Angiotensin (1–7) and Angiotensin II Type 1 Receptor–Biased Ligand in Adults With COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renin-Angiotensin System Modulation With Synthetic Angiotensin (1-7) and Angiotensin II Type 1 Receptor-Biased Ligand in Adults With COVID-19: Two Randomized Clinical Trials
JAMA 2023 Apr 11;329(14)1170-1182, WH Self, MS Shotwell, KW Gibbs, M de Wit, DC Files, M Harkins, KM Hudock, LH Merck, A Moskowitz, KD Apodaca, A Barksdale, B Safdar, A Javaheri, JM Sturek, H Schrager, N Iovine, B Tiffany, IS Douglas, J Levitt, LW Busse, AA Ginde, SM Brown, DN Hager, K Boyle, A Duggal, A Khan, M Lanspa, P Chen, M Puskarich, D Vonderhaar, L Venkateshaiah, N Gentile, Y Rosenberg, J Troendle, AJ Bistran-Hall, J DeClercq, R Lavieri, MM Joly, M Orr, J Pulley, TW Rice, JS Schildcrout, MW Semler, L Wang, GR Bernard, SP CollinsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.